Synergy CHC Corp. 8-K Filing Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 29, 2026, details the results of Synergy CHC Corp.'s 2026 Annual Meeting of Stockholders. The company is incorporated in Nevada and its common stock (Symbol: SNYR) trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and stockholder voting results.
Material Changes and Voting Results
On the record date of April 24, 2026, there were 14,899,883 shares of Common Stock outstanding. Approximately 65% of eligible votes were represented at the meeting. Stockholders approved the following key proposals:
- Director Elections: Five directors (Alfred Baumeler, Nitin Kaushal, Jack Ross, J. Paul SoRelle, and Teresa Thompson) were elected to serve until the 2027 annual meeting.
- Equity Plan Amendment: Approved an amendment to the 2024 Equity Incentive Plan to increase the share pool to 150,000,000 shares and to permit the repricing of outstanding awards.
- Warrant Issuance: Approved the full issuance of shares upon exercise of the Lender Warrant to comply with Nasdaq Listing Rules 5635(b) and 5635(d).
- Reverse Stock Split: Authorized the Board to execute one or more reverse stock splits at ratios not exceeding an aggregate of 1-for-200.
- Auditor Ratification: Ratified the appointment of RBSM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the implications of the approved corporate actions. The approval of the reverse stock split and warrant issuance indicates a strategic focus on maintaining Nasdaq listing compliance.
Investor Verification Checklist
- Verify the specific ratio and timing of the reverse stock split once determined by the Board.
- Review the full text of Exhibit 10.1 (Amendment No. 3 to the 2024 Equity Incentive Plan) for details on repricing mechanics.
- Monitor the impact of the 150,000,000 share increase on existing shareholder dilution.
- Confirm the number of shares issued upon the exercise of the Lender Warrant in subsequent filings.